PACB Pangali Forward P/E Pacific Biosciences of California, Inc.
Pacific Biosciences is recognized as an authoritative expert in long-read genome sequencing, enjoying a high level of trust among scientists. The business relies on the creation of advanced DNA sequencing systems while implementing eco-friendly methods to reduce plastic and chemical use. This stock price chart on GURU.Markets shows a P/E ratio of 0.00, visualizing the market valuation of this innovative developer.
Rincian metrik keuangan lan pasar Pacific Biosciences (PACB)
- kuotasi lan prakiraan analis:
- data kapitalisasi pasar:
- informasi kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Rasio Total Utang marang Ekuitas Pacific Biosciences|PACB - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal PacBio|PACB - Utang perusahaan|Utang-utang marang kapitalisasi buku Pacific Biosciences of California, Inc.|PACB - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan PacBio|Likuiditas cepet pacb.com
- statistik bathi lan rasio pasar:
PACB - Asil keuangan resik|Proyeksi bathi mangsa ngarep Pacific Biosciences|PACB - Koefisien rega marang bathi|Pangali Forward P/E pacb.com|PACB - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Pacific Biosciences|PACB - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan PacBio|PACB - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan pacb.com|PACB - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Pacific Biosciences
- data pendapatan lan penerimaan dodolan:
Analisis umum perusahaan:PacBio Corp
Market expectations often precede the current financial results of growth companies. The indicator is calculated as the ratio of the current share price to the projected earnings for the future period. By analyzing the forward P/E chart for Pacific Biosciences (PACB) on GURU.Markets, an investor assesses the extent of the premium paid for future success. For a DNA sequencing leader with an impeccable reputation, a high valuation is justified by technological superiority. This allows for a balance between valuation risk and long-term growth potential.
Pesaing utama
Prakiraan rega marang bathi TEM (Tempus AI, Inc)|Qiagen Group (QGEN) - Pangali forward rega marang bathi|Rega marang bathi mangsa ngarep ionispharma.com IONS|Kapitalisasi marang proyeksi bathi Repligen Corporation (RGEN)|RNA: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CRSP (CRISPR Therapeutics Corp)|WGS: Pangali Forward P/E|Rasio prakiraan rega marang bathi Ultragenyx Corp (RARE)|BEAM (Beam Therapeutics Inc) - Pangali Forward P/E|SRPT: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Twist Bioscience Corp (TWST)|Prakiraan rega marang bathi 10x Genomics Inc TXG|Intellia Therapeutics, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi STOK|BLFS - Rega marang bathi mangsa ngarep|Wave Life Sciences (WVE) - Prakiraan rega marang bathi|MAZE: Pangali Forward P/E|Sionna Therapeutics, Inc. (SION) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Prime Medicine, Inc.|TSHA (Taysha) - Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi QURE (uniQure Pharma)|Kapitalisasi marang proyeksi bathi meiragtx.com|Rega marang bathi mangsa ngarep REGENXBIO RGNX|SLDB - Prakiraan rega marang bathi|Ocugen, Inc. - Pangali Forward P/E|Benitec (BNTC) - Prakiraan rega marang bathi|DSGN: Pangali Forward P/E|RCKT: Rasio kapitalisasi marang bathi mangsa ngarep|FDMT (4D Molecular Therapeutics, Inc.) - Pangali Forward P/E|lexeotx.com (LXEO) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E KRRO|Prakiraan rega marang bathi Editas Medicine, Inc. EDIT|Rega marang bathi mangsa ngarep silence-therapeutics.com SLN|PRQR: Rasio rega marang bathi mangsa ngarep|CDXS - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Sangamo Therapeutics, Inc. SGMO|NAUT (nautilus.bio) - Prakiraan rega marang bathi|Rasio prakiraan rega marang bathi Metagenomi, Inc. (MGX)|Prakiraan rega marang bathi DTIL|Rasio rega marang bathi mangsa ngarep GBIO (generationbio.com)|Rega marang bathi mangsa ngarep Boundless Bio, Inc (BOLD)|Pangali Forward P/E Exicure Inc. (XCUR)|Imunon, Inc. - Prakiraan rega marang bathi|PHIO: Rasio rega marang bathi mangsa ngarep|MBIO - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake RNAZ|Bionano Genomics, Inc. (BNGO) - Rega marang bathi mangsa ngarep|Applied DNA Sciences, Inc. (APDN) - Pangali Forward P/E|BLUE (bluebirdbio.com) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep IPA (ImmunoPrecise Antibodies)|Pangali Forward P/E OMGA|Prakiraan rega marang bathi Singular Genomics Systems OMIC|Pangali Forward P/E RGLS (regulusrx.com)|Syros Pharmaceuticals Inc. (SYRS) - Rasio prakiraan rega marang bathi|TBIO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TCON (TRACON)|UBX: Pangali Forward P/E
